Your browser doesn't support javascript.
loading
Doxorubicin-induced central nervous system toxicity and protection by xanthone derivative of Garcinia mangostana.
Tangpong, J; Miriyala, S; Noel, T; Sinthupibulyakit, C; Jungsuwadee, P; St Clair, D K.
Afiliación
  • Tangpong J; School of Allied Health Sciences and Public Health, Thasala, Nakhon-Si-Thammarat, Thailand.
Neuroscience ; 175: 292-9, 2011 Feb 23.
Article en En | MEDLINE | ID: mdl-21074598
Doxorubicin (Dox) is a potent, broad-spectrum chemotherapeutic drug used around the world. Despite its effectiveness, it has a wide range of toxic side effects, many of which most likely result from its inherent pro-oxidant activity. It has been reported that Dox has toxic effects on normal tissues, including brain tissue. The present study tested the protective effect of a xanthone derivative of Garcinia Mangostana against Dox-induced neuronal toxicity. Xanthone can prevent Dox from causing mononuclear cells to increase the level of tumor necrosis factor-alpha (TNFα). We show that xanthone given to mice before Dox administration suppresses protein carbonyl, nitrotyrosine and 4-hydroxy-2'-nonenal (4HNE)-adducted proteins in brain tissue. The levels of the pro-apoptotic proteins p53 and Bax and the anti-apoptotic protein Bcl-xL were significantly increased in Dox-treated mice compared with the control group. Consistent with the increase of apoptotic markers, the levels of caspase-3 activity and TUNEL-positive cells were also increased in Dox-treated mice. Pretreatment with xanthone suppressed Dox-induced increases in all indicators of injury tested. Together, the results suggest that xanthone prevents Dox-induced central nervous system toxicity, at least in part, by suppression of Dox-mediated increases in circulating TNFα. Thus, xanthone is a good candidate for prevention of systemic effects resulting from reactive oxygen generating anticancer therapeutics.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Fármacos Neuroprotectores / Garcinia mangostana / Xantonas / Neurotoxinas / Antineoplásicos Fitogénicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Neuroscience Año: 2011 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Doxorrubicina / Fármacos Neuroprotectores / Garcinia mangostana / Xantonas / Neurotoxinas / Antineoplásicos Fitogénicos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Neuroscience Año: 2011 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Estados Unidos